Ibuprofen Caplets USP 200 mg recalled over manufacturing violations
- Recall date
- January 11, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Time-Cap Laboratories, Inc. recalls Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC…
- Recall number
- D-0694-2018
- FDA classification
- Class II
- Brand / firm
- Time-Cap Laboratories, Inc.
- Sold / distributed
- Nationwide.
Why it was recalled
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC 49483-600-50), and d) BULK (NDC 49483-600-00) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India
Get recall alerts
Free email alert whenever Time-Cap Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Time-Cap Laboratories, Inc.